Lyra Health Advances Health Equity With Proactive Social Care Solution
Lyra Therapeutics Granted U.S. Patent #12036337 For "IMPLANTABLE SCAFFOLDS FOR TREATMENT OF SINUSITIS".
Express News | Cantor Fitzgerald Reiterates Overweight on Lyra Therapeutics
Lyra Therapeutics Analyst Ratings
Express News | Lyra Therapeutics Estimates That It Will Incur Charges Of About $3.9M-$4.1M In Connection With The Workforce Reduction; Expects That The Majority Of Charges Related To Workforce Reduction Will Be Incurred In Q2 Of 2024
Express News | Lyra Therapeutics: Expects That the Majority of Charges Related to Workforce Reduction Will Be Incurred in the Second Quarter of 2024
Express News | Lyra Therapeutics:Estimates That It Will Incur Charges of About $3.9 to $4.1 Million in Connection With the Workforce Reduction
Express News | Trading Halt: Halt Status Updated at 9:40:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Lyra Therapeutics Inc - Reduction in Force Included John E. Bishop, Company's Chief Technology Officer
Express News | Lyra Therapeutics Inc: Measures Are Expected to Extend Lyra's Cash Runway Into 2026
Express News | Lyra Therapeutics - Stopped Manufacturing and Commercialization Efforts and Seeks to Sublease Its Facilities to Reduce Operating Costs
Express News | Lyra Therapeutics Inc - in Parallel, Company Plans to Evaluate Potential Strategic Options to Maximize Shareholder Value
Express News | Lyra Therapeutics Inc - Lyra Has Paused Efforts for Lyr-220
Express News | Lyra Therapeutics Inc: In Near Term, Lyra Therapeutics Will Focus on Two Ongoing Enlighten Phase 3 Trials Evaluating Lyr-210
Express News | Lyra Therapeutics Inc: Implementing a Layoff of Approximately 75% of Its Workforce
Express News | Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital
Express News | Trading Halt: Halted at 8:55:00 A.m. ET - Trading Halt: Halt News Pending
Express News | New Post-Hoc Analysis Of Pooled Phase 3 Data Shows That INPEFA (Sotagliflozin) Reduced Risk Of Heart Failure Events In Patients With Preserved Ejection Fraction
12 Health Care Stocks Moving In Tuesday's Intraday Session
Jefferies Cuts Lyra to Hold in Wake of Failed Phase 3 Study